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Abstract: This beagle pulpotomy study compared the inflammatory response and mineralization-
inducing potential of three calcium silicate cements: ProRoot mineral trioxide aggregate (MTA)
(Dentsply, Tulsa, OK, USA), OrthoMTA (BioMTA, Seoul, Korea), and Endocem MTA (Maruchi,
Wonju, Korea). Exposed pulp tissues were capped with ProRoot MTA, OrthoMTA, or Endocem MTA.
After 8 weeks, we extracted the teeth, then performed hematoxylin-eosin and immunohistochemical
staining with osteocalcin and dentin sialoprotein. Histological evaluation comprised a scoring system
with eight broad categories and analysis of calcific barrier areas. We evaluated 44 teeth capped with
ProRoot MTA (n = 15), OrthoMTA (n = 18), or Endocem MTA (n = 11). Most ProRoot MTA specimens
formed continuous calcific barriers; these pulps contained inflammation-free palisading patterns
in the odontoblastic layer. Areas of the newly formed calcific barrier were greater with ProRoot
MTA than with Endocem MTA (p = 0.006). Although dentin sialoprotein was highly expressed
in all three groups, the osteocalcin expression was reduced in the OrthoMTA and Endocem MTA
groups. ProRoot MTA was superior to OrthoMTA and Endocem MTA in all histological analyses.
ProRoot MTA and OrthoMTA resulted in reduced pulpal inflammation and more complete calcific
barrier formation, whereas Endocem MTA caused a lower level of calcific barrier continuity with
tunnel defects.
Keywords: calcium silicate cements; pulpal response; mineralization; calcific barrier; inflammation;
odontoblastic layer
1. Introduction
Vital pulp therapy consists of apexogenesis, pulpotomy, pulpal debridement, indirect pulp
capping, and direct pulp capping [1]. The aim of these treatments includes maintenance of vitality
and preservation of the remaining pulp to enable adequate healing of the pulp-dentin complex [2,3].
These procedures offer a more conservative approach to root canal therapy for traumatic and cariously
exposed pulps [4,5]. ProRoot mineral trioxide aggregate (PMTA) (Dentsply, Tulsa, OK, USA) has been
recognized as an appropriate material for vital pulp therapy, and has provided higher clinical success
rates in a long-term study [6].
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Although PMTA possesses bioactive and antibacterial activities with high sealing properties [7–10],
it has some drawbacks such as a prolonged setting time, discoloration potential, and difficult
handling properties [11]. Recently, calcium silicate cement development has helped to overcome
these disadvantages in the search for bioactive dental materials. These include OrthoMTA (OMTA;
BioMTA) and Endocem MTA (EMTA; Maruchi, Wonju, Korea).
OMTA contains lower concentrations of heavy metals for greater biocompatibility [12] and has a
low expansion rate and a good sealing ability [13]. According to the manufacturer, OMTA prevents
microleakage by forming a layer of hydroxyapatite that acts as an interface between the material and
the canal wall [14]. Moreover, it has been reported to create a favorable environment for bacterial
entombment through intratubular mineralization [15]. Clinical studies reported that both PMTA
and OMTA had high success rates in pulpotomy and partial pulpotomy when used in primary and
permanent teeth [16,17]. However, OMTA showed lower biocompatibility compared with PMTA in
an in vitro study [18]. EMTA has been introduced as an MTA-derived pozzolan cement. EMTA has
a short setting time (around 4 min) without the addition of a chemical accelerator because it uses a
pozzolanic reaction [19]. It is convenient to handle based on its adequate consistency and washout
resistance [20]. Indeed, EMTA demonstrated good biocompatibility, osteogenicity, and odontogenic
effects similar to PMTA in an in vitro study [19].
Despite the increased use of various calcium silicate cements in vital pulp therapy, their effects after
pulpotomy in an in vivo animal model have not yet been investigated. In addition, most studies have
had short durations of approximately 4 weeks. Accordingly, the present study aimed to evaluate and
compare levels of calcific barrier formation, inflammation reaction, and hard tissue barrier formation
histologically following the application of PMTA, OMTA, and EMTA for 8 weeks in a beagle pulpotomy
model. The null hypothesis is that there is no significant difference in inflammatory response and
mineralization-inducing potentials among the three materials; both OMTA and EMTA have similar
biologic effects to PMTA.
2. Materials and Methods
2.1. Animal Model
The present study used a beagle dog pulpotomy model. The inclusion criteria were non-damaged
dentition and healthy periodontium. The teeth of two dogs were numbered and randomly divided
into three groups with a table of random sampling numbers; the three calcium silicate material groups
are shown in Table 1. We performed animal selection, control, the surgical operation, and preparation
as per the procedures approved by the Yonsei University Health System’s Institutional Animal Care
and Use Committee (certification #2013-0317-4). These experiments were performed in accordance
with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Table 1. The chemical compositions of the calcium silicate cements tested in this study.
Materials Composition Setting Time
PMTA
Tricalcium silicate
Initial setting time: 78 min (±5 min)
Final setting time: 261 min (±21 min)
Tricalcium aluminate
Dicalcium silicate
Tetracalcium aluminoferrite
Gypsum
Free calcium oxide
Bismuth oxide
OMTA
Tricalcium silicate
Initial setting time: 180 min
Final setting time: 360 min (±21 min)
Dicalcium silicate
Tricalcium aluminate
Tetracalcium aluminoferrite
Free calcium oxide
Bismuth oxide
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Table 1. Cont.
Materials Composition Setting Time
EMTA
Calcium oxide
Initial setting time: 2 min (±30 s)
Final setting time: 4 min (±30 s)
Silicon dioxide
Bismuth oxide
Aluminum oxide
H2O/CO2
Magnesium oxide
Sulfur trioxide
Ferrous oxide
Titanium dioxide
PMTA, ProRoot MTA® (Dentsply Tulsa, OK, USA); OMTA, Ortho MTA® (BioMTA, Seoul, Korea); EMTA, Endocem
MTA® (Maruchi, Wonju, Korea).
2.2. Surgical Procedure
We performed all operations in a clean, sterilized room. We administered intravascular
injections of tiletamine/zolazepam (Zoletile® 5 mg/kg; Virbac Korea, Seoul, Korea) and xylazine
(Rompun® 0.2 mg/kg; Bayer Korea, Seoul, Korea), and used the inhalational anesthetic isoflurane
(Gerolan®, Choongwae Pharmaceutical, Seoul, Korea) for general anesthesia induction. To prevent
infection, we injected enfloxacin (5 mg/kg) subcutaneously immediately before and after the operation.
We administered amoxicillin clavulanate (12.5 mg/kg) orally for 5 to 7 days after the operation.
2.3. Pulpotomy Procedure
We used lidocaine hydrochloride (2%) with 1:100,000 epinephrine (Kwangmyung Pharmaceutical,
Seoul, Korea) for local anesthesia. After forming a cavity on the occlusal surface using a high-speed
carbide bur #330 (H7 314 008, Brasseler, Lemgo, Germany), we mechanically exposed the pulp. We
removed the crown of the pulp at the level of the cementoenamel junction and stopped bleeding by
injecting sterile saline and applying slight pressure with sterile cotton pellets. We applied the MTA to
the top of the cut pulp as per the manufacturer’s guidelines in each group. When we applied the MTA
to the pulp area, we used cotton balls soaked in saline. We performed the final cavity restoration using
the self-curing glass ionomer cement Ketac-Molar (3M ESPE; St. Paul, MN, USA). Eight weeks after
the operation, we euthanized the dogs by over-sedation.
2.4. Histological Analysis
We extracted the teeth with forceps and removed one-third of the root using a high-speed bur.
We fixed the specimens in 10% neutral-buffered formalin (Sigma-Aldrich, St. Louis, MO, USA) for 48 h,
and demineralized them in ethylenediaminetetraacetic acid (EDTA; pH 7.4; Fisher Scientific, Houston,
TX, USA) for 6 weeks before embedding them in paraffin. For each specimen, we created 3-µm
continuous sections in the buccolingual direction and stained them subsequently with hematoxylin
and eosin (HE). We used InnerView 2.0 software (InnerView Co., Seongnam-si, Gyeonggi-do, Korea) for
image analysis. Five observers blinded to the group allocations examined the specimens. We evaluated
the specimens for calcific barrier formation, dental pulp inflammation, and odontoblastic cell layer
formation with a scoring system reported in a previous study [21–23] (Table 2). We adopted the score
agreed upon by at least three of the five observers who were blinded to specimen grouping. In addition,
we measured the area of the newly formed hard tissue using ImageJ version 1.48 (National Institute of
Health, Bethesda, MD, USA).
2.5. Immunohistochemistry
For immunohistochemistry (IHC), we deparaffinized 3-µm cross-sections with xylene, rehydrated
them, and rinsed them with distilled water. For antigen retrieval, we used protease K (Dako North
America Inc., Carpinteria, CA, USA) for osteocalcin (OC) and dentin sialoprotein (DSP) staining.
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To activate endogenous peroxidase, we added 3% hydrogen peroxide, while preventing non-specific
binding by incubating sections in 5% bovine serum albumin (Sigma-Aldrich). Subsequently, we incubated
sections overnight with the following primary antibodies: anti-OC antibody (rabbit polyclonal, Ab109112,
1:10,000; Abcam, Cambridge, UK) or anti-DSP antibody (rabbit polyclonal, sc-33586, 1:500; Santa
Cruz Biotechnology, Santa Cruz, CA, USA). Subsequently, we applied EnVision + System-Horseradish
peroxidase (HRP)-Labeled Polymer anti-rabbit (K4003, Dako) for 20 min. After developing color using
the labeled streptavidin biotin kit (Dako) as per the manufacturer’s guidelines, we counterstained the
sections with Gill’s hematoxylin (Sigma-Aldrich).
Table 2. Scores used during the histological analysis of calcific barriers and dental pulp.
Scores Calcific Barrier Continuity
1 Complete calcific barrier formation
2 Partial/incomplete calcific barrier formation extending to more than one-half of the exposure site butnot completely closing the exposure site
3 Initial calcific barrier formation extending to no more than one-half of the exposure site
4 No calcific barrier formation
Scores Calcific barrier morphology
1 Dentin or dentin-associated with irregular hard tissue
2 Only irregular hard tissue deposition
3 Only a thin layer of hard tissue deposition
4 No hard tissue deposition
Scores Tubules in calcific barrier
1 No tubules present
2 Mild (tubules present in less than 30% of the calcific barrier)
3 Moderate to severe (tubules present in more than 30% of the calcific barrier)
4 No hard tissue deposition
Scores Inflammation intensity
1 Absent or very few inflammatory cells
2 Mild (an average of <10 inflammatory cells)
3 Moderate (an average of 10–25 inflammatory cells)
4 Severe (an average >25 inflammatory cells)
Scores Inflammation extensity
1 Absent
2 Mild (inflammatory cells next to the dentin bridge or area of pulp exposure only)
3 Moderate (inflammatory cells observed in one-third or more of the coronal pulp or in the mid pulp)
4 Severe (all of the coronal pulp is infiltrated or necrotic)
Scores Inflammation type
1 No inflammation
2 Chronic inflammation
3 Acute and chronic inflammation
4 Acute inflammation
Scores Dental pulp congestion
1 No congestion
2 Mild (enlarged blood vessels next to the dentin bridge or area of pulp exposure only)
3 Moderate (enlarged blood vessels observed in one-third or more of the coronal pulp or in the mid pulp)
4 Severe (all of the coronal pulp is infiltrated with blood cells)
Scores Odontoblastic cell layer
1 Complete palisading cell pattern
2 Partial/incomplete palisading cell pattern
3 Presence of odontoblast-like cells only
4 Absent
2.6. Statistical Analysis
We performed statistical analyses using SPSS version 23 software (SPSS, Chicago, IL, USA).
To analyze the area of the newly formed calcific barrier, we applied a one-way analysis of variance
(ANOVA) (significance at p < 0.05) and the post hoc Scheffé test (Bonferroni correction; p < 0.017).
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3. Results
The present study used two male beagle dogs aged 18–24 months that weighed approximately
12 kg. We selected 60 teeth from the two dogs. Among the 60 teeth, we excluded five teeth from the
PMTA group, two from the OMTA group, and nine from the EMTA group that failed during tooth
removal or specimen production; we evaluated only 44 specimens in the final analysis. Eventually,
we analyzed the PMTA (n = 15), OMTA (n = 18), and EMTA (n = 11) specimens histologically.
3.1. Calcific Barrier Formation
Most specimens in the PMTA group formed a complete calcific barrier, while some in the
OMTA and EMTA groups produced a partially discontinuous calcific barrier (Figure 1 and Table 3).
We observed no calcific barrier in only one specimen from the EMTA group (Figure 2B). In addition,
the PMTA group produced hard tissue most similar to the dentin, while we observed a partially
irregular or thinly formed calcific layer in the OMTA and EMTA groups. Although three groups
contained calcific barriers with low tubule formation (Figure 2D), moderate to severe tubule formation
in calcific barrier was found in an OMTA specimen (Figure 2C). We compared the areas of the formed
calcific barriers; the calcific barrier in the PMTA group was the widest, followed by those in the OMTA
and EMTA groups. There was a statistically significant difference between the PMTA and EMTA
groups (p = 0.006; Figure 3E). When the calcific barriers were standardized with coronal pulpal width
according to tooth type, PMTA also had a significantly higher area than EMTA (p = 0.0114; Figure 3F).
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Figure 1. Hematoxylin-eosin staining for the evaluation of the histomorphologic characteristics of the 
newly formed calcific barrier (CB) after 8 weeks. Most PMTA and OMTA specimens formed 
continuous CBs and the pulps contained palisading patterns in the odontoblastic layer that were free 
from inflammation. However, EMTA specimens showed less favorable odontoblastic layer formation 
((A–C): scale bars = 250 µm, (D–F): scale bars = 50 µm). 
Figure 1. Hematoxylin-eosin staining for the evaluation of the histomorphologic characteristics of
the newly formed calcific barrier (CB) after 8 weeks. Most PMTA and OMTA specimens formed
continuous CBs and the pulps contained palisading patterns in the odontoblastic layer that were free
from inflammation. However, EMTA specimens showed less favorable odontoblastic layer formation
((A–C): scale bars = 250 µm, (D–F): scale bars = 50 µm).
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Table 3. Score percentages for calcific barriers.
Groups
Calcific Barrier Continuity (%)
1 2 3 4
PMTA 100 (15/15) * - - -
OMTA 66.67 (12/18) 16.67 (3/18) 16.67 (3/18) -
EMTA 45.45 (5/11) 18.18 (2/11) 27.27 (3/11) 9.09 (1/11)
Groups
Calcific Barrier Morphology (%)
1 2 3 4
PMTA 86.67 (13/15) 13.33 (2/15) - -
OMTA 38.89 (7/18) 27.78 (5/18) 33.33 (6/18) -
EMTA 45.45 (5/11) 18.18 (2/11) 27.27 (3/11) 9.09 (1/11)
Groups
Tubules in Calcific Barrier (%)
1 2 3 4
PMTA 60 (9/15) 33.33 (5/15) 6.67 (1/15) -
OMTA 61.11 (11/18) 27.78 (5/18) 11.11 (2/18) -
EMTA 63.64 (7/11) 18.18 (2/11) 9.09 (1/11) 9.09 (1/11)
PMTA, ProRoot MTA®; OMTA, Ortho MTA®; EMTA, Endocem MTA®. * (number of teeth receiving the score/total
number of teeth evaluated).
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Figure 2. (A) An example of a pulpotomy procedure. The site of pulpotomy (yellow arrow) was
an upper part of the calcific barrier (red arrow). MTA was filled in the pulp exposure area, but the
material is not visible due to partial loss during specimen processing (blue arrow); (B) An EMTA
specimen without a calcific barrier (yellow arrow). This corresponds to score 4 in the calcific barrier
continuity category; (C) oderate to severe tubule formation in calcific barrier of an OMTA specimen
(red a row); (D) A PMTA specim n with comp ete calcific barrier formation and n tubule in barrier
(red arrow). It also has complete palisading cell pattern i odontoblastic cell layer (yellow arrow);
(E) An EMTA sp cimen with absent odontoblastic cell layer under calcific b rrier. This corresponds to
score 4 in the odontoblastic cell layer category; (F–H) Inflammatory cells that are observed in coronal
and middle pulps.
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Figure 3. The area of the newly for alcific barrier for each material after 8 weeks. (A) The
distributions of tooth types among th t t st groups; (B) An example measuring coronal pulpal
width and calcific barrier thickness; Although the ickness of the calcific barriers did not vary according
to tooth type (C); the width of the coronal pulp differed by tooth type (p = 0.0126) (D). Thus, the area of
the calcific barrier was calculated by dividing by the horizontal width of the coronal pulp. The bars
represent the mean ± the standard deviation; (E) In the PMTA group, the calcific barrier is widest,
followed by those in the OMTA and EMTA groups. There is a statistically significant difference between
the PMTA and EMTA groups (p = 0.006); (F) When the calcific barriers were standardized by coronal
pulpal width, PMTA also had a significantly higher area than EMTA (p = 0.0114). We performed
statistical analyses with a one-way ANOVA and the post hoc Scheffé test. The number of specimens is
n = 15 in the PMTA group, n = 18 in the OMTA group, and n = 11 in the EMTA group.
3.2. Pulpal Reaction
We observed mononuclear inflammatory cells in 26.67% of the specimens from the PMTA group,
44.44% from the OMTA group, and 63.64% from the EMTA group (Table 4). When we compared the
extent of inflammation among the groups, inflammation was mild or almost absent in the PMTA and
OMTA groups. In 9% of the EMTA specimens, we observed inflammatory cells in one-third or more of
the coronal pulp or middle pulp. While there was almost no acute inflammation in any group, a few
cases demonstrated chronic inflammatio exclusively. The pulpal congestion reaction was mild in
the PMTA group and most severe in the EMTA group. We observed no pulpal congestion above the
moderate level in any of the three groups.
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Table 4. Score percentages for inflammatory responses.
Groups
Inflammation Intensity (%)
1 2 3 4
PMTA 73.33 (11/15) * 26.67 (4/15) - -
OMTA 55.56 (10/18) 44.44 (8/18) - -
EMTA 36.36 (4/11) 63.64 (7/11) - -
Groups
Inflammation Extensity (%)
1 2 3 4
PMTA 73.33 (11/15) 26.67 (4/15) - -
OMTA 55.56 (10/18) 44.44 (8/18) - -
EMTA 36.36 (4/11) 54.55 (6/11) 9.09 (1/11) -
Groups
Inflammation Type (%)
1 2 3 4
PMTA 73.33 (11/15) 26.67 (4/15) - -
OMTA 55.56 (10/18) 44.44 (8/18) - -
EMTA 36.36 (4/11) 63.64 (7/11) - -
Groups
Dental Pulp Congestion (%)
1 2 3 4
PMTA 40 (6/15) 53.33 (8/15) 6.67 (1/15) -
OMTA 27.78 (5/18) 61.11 (11/18) 11.11 (2/18) -
EMTA 18.18 (2/11) 63.64 (7/11) 18.18 (2/11) -
* (number of teeth receiving the score/total number of teeth evaluated).
3.3. Odontoblastic Cell Layer
In the PMTA group, a complete palisading cell pattern was visible in 60% of the specimens, with
26.67% showing Partial/incomplete palisading cell pattern (Table 5). The OMTA and EMTA groups
showed less favorable results compared with the PMTA group: all OMTA specimens showed an
odontoblastic cell layer. In contrast, approximately 9.09% of the EMTA group specimens showed no
odontoblastic cell layer.
Table 5. Score percentages for the odontoblastic cell layer.
Groups
Odontoblastic Cell Layer (%)
1 2 3 4
PMTA 60 (9/15) * 26.67 (4/15) 13.33 (4/15) -
OMTA 33.33 (6/18) 50 (9/18) 16.67 (3/18) -
EMTA 45.45 (5/11) 18.18 (2/11) 27.27 (3/11) 9.09 (1/11)
* (number of teeth receiving the score/total number of teeth evaluated).
3.4. Immunohistochemistry
DSP and OC staining indicated hard tissue formation in all three groups. The DSP was highly
expressed in all three groups, which indicated odontogenic differential potential (Figure 4A–F).
Although OC was also expressed in all three groups, its expression was relatively less in the EMTA
group (Figure 4G–L).
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Figure 4. Immunohistochemical staining of dentin sialoprotein (DSP) and osteocalcin (OC). The DSP is
highly expressed in all three groups. Although OC is expressed most clearly in odontoblast-like cells in
the PMTA group, its expression was reduced in the EMTA group. Yellow arrows indicate cells with a
positive signal. ((A–C,G–I): scale bars = 150 µm; (D–F,J–L): scale bars = 50 µm).
4. Discussion
Many attempts have been made to improve the clinical application of MTA by modifying
chemical components or adding a setting accelerator; however, it is important to note that changes in
MTA components may cause adverse effects with respect to physical and biological properties [24].
We recommend that in vivo studies explore the pulpal response when using MTA for vital pulp
therapy. We recently reported the pulpal responses to pulpotomy with RetroMTA, TheraCal (Bisco Inc.,
Schamburg, IL, USA), and PMTA [22], and compared the biological efficacies of Endocem Zr (Maruchi,
Wonju, Korea) and PMTA at 4 weeks in an in vivo study [23]. We performed this study to compare
and evaluate the pulpal response associated with PMTA, OMTA, and EMTA over 8 weeks in a beagle
dog pulpotomy model. To our knowledge, this is the first study to examine the biological response
from OMTA compared with those from EMTA and PMTA simultaneously in an in vivo model.
Overall, both PMTA and OMTA showed favorable pulpal reactions and formed an almost
complete calcific barrier. EMTA induced a slightly greater inflammatory reaction than the other
two MTAs and had a lower amount of calcific barrier formation with tunnel defects. These results
suggested that EMTA had relatively less biocompatibility than PMTA or OMTA. In addition, PMTA
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and OMTA formed favorable palisading patterns in odontoblast cells, which demonstrate that these
materials had stronger odontogenic differentiation potential.
We suggest several reasons for the low biocompatibility of EMTA observed in this study.
A study reported that EMTA resulted in lower cell viability than PMTA immediately after mixing
because of its high pH and the heat from the cement surface [25]. This initial cytotoxic effect might
contribute to denaturation of adjacent cells [26]. EMTA was also known to express a lower level
of osteopontin, a specific bone mineralization marker, compared with other MTAs [27]. Reduced
osteopontin production could be a result of lower hard tissue formation. However, these results
were not in accordance with the results of a previous in vitro study, which reported that OMTA was
significantly more cytotoxic than PMTA and EMTA [27]. The difference may result from interactions
with living cells; chemical reactions in the dentin-MTA interfacial layer might have caused the
differences in results between the in vivo and in vitro study models. In addition, while PMTA and
OMTA exhibit similar components, EMTA contains different chemicals, such as small particles of
pozzolan. A pozzolan is a siliceous and aluminous material that reacts chemically with calcium
hydroxide to form calcium silicate hydrate in the presence of water [28]. Unlike the initially high
pH levels after mixing, EMTA showed a significantly lower pH value than PMTA and OMTA [29].
A previous study found that an acidic environment adversely affected the physical properties and
hydration behavior of MTA [30]. We recommend further study because EMTA had inferior cell viability
and a low pH level after setting, but was not significantly different from the other two MTAs.
Despite the small number of reports regarding OMTA and EMTA, various in vivo and clinical
studies have demonstrated successful formation of calcific barriers in vital pulp therapy with
PMTA [16,17,22,23,31,32]. It is still controversial whether calcific barrier formation at the interface
between the pulp and material indicates the success of the treatment. Therefore, to judge the efficacy
of different MTAs, it is important to analyze the presence or absence of inflammation (the type
and severity) and the continuity, structure, and tubule formation of the formed calcific barrier [33].
This study interpreted the calcific barrier as a sign of healing and a positive reaction to stimulation.
In the three MTA groups, the calcific barrier interfaces had columnar cells projecting into the bridge
with polarized nuclei, which indicates the formation of odontoblast cells and reparative dentin
synthesis. This study also confirmed odontogenic properties with IHC by using OC and DSP. OC is a
specific marker of the late odontoblastic development pathway and DSP is a marker of odontoblast
regulation in reparative dentin mineralization [34]. In regards to several molecular mechanisms,
in vitro studies with PMTA showed continuously increasing transcription of mRNA for DSP [35].
Further, upregulation of OC mRNA confirmed the odontoblastic pathway of cell differentiation,
indicating that cells enter a quiescent phase in another calcium silicate cement, Biodentine [36]. IHC
revealed that PMTA had the potential to induce greater odontoblastic differentiation than OMTA or
EMTA. In the analysis of the mean calcific barrier areas, the areas of newly formed calcific barrier were
significantly greater in the PMTA group than in the EMTA group. When comparing the area of newly
formed calcific barrier in this study statistically, the size of the pulp would be different according to
the type of tooth. Although we tried to distribute the tooth types evenly among the experimental
groups, we excluded some specimens during tooth removal and specimen production, especially in
the EMTA group. Further, the PMTA was regarded as a positive control, but there was no negative
control group in this experiment. We recommend further study with a larger sample and the inclusion
of a negative control.
In the present study, we evaluated the pulpal response in pulpotomy model for a period of
8 weeks. Other studies used the same time interval [37,38]. In one study, osteodentin matrix formation
occurred during the first 2 weeks; after 3 weeks, a complete layer of reparative dentin was formed
at the capping site [39]. Another study reported the presence of a calcified bridge in all specimens at
5 weeks after capping with MTA [34]. Notably, we designed the study to compare pulpal responses in
a previous study with a shorter time interval (4 weeks) to determine whether there was any difference
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in response, compared with an 8-week interval. At 8 weeks, hard tissue formation at the exposure site
was thicker with less inflammation than in our previous in vivo study at 4 weeks [22,23].
The results of the animal model may not correspond with those of human teeth. A complete
hard tissue barrier appeared 1 week after pulp capping in canine teeth [33], whereas the initiation of
hard tissue formation has been reported to start as early as 2 weeks after pulp capping in humans [40].
Most studies reported that it took 30 to 42 days to form a hard tissue barrier in humans [41,42].
In addition, we performed the evaluation of the pulpal response on healthy, intact teeth from dogs.
Therefore, these results do not necessarily reflect the effects of newly developed MTAs on inflamed
pulps. We advise clinicians to place a wet cotton pellet over the MTA in the first visit, followed by
replacement with a permanent restoration at the second visit. In this experiment under G/A, the long
setting time of PMTA and OMTA was a limitation. Accordingly, careful consideration is necessary
when adapting these results to clinical situations.
In conclusion, the results of the present in vivo study demonstrated that PMTA and OMTA had
favorable outcomes when used as pulpotomy materials. Both materials showed biocompatibility
and induced high-quality calcific barrier formation at the interface with the pulp tissue. However,
EMTA has appropriate characteristics and clinical advantages of a shorter setting time and no tooth
discoloration. Regarding the application of these results on pulpotomy in healthy canine pulps with
no inflammation, we recommend further clinical studies using human teeth for an evaluation of the
biological efficacy of these materials.
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